BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31278706)

  • 1. A novel realgar-indigo naturalis formula more effectively induces apoptosis in NB4 cells.
    Xie Q; Yu L; Wang X; Wu Z; Zhi D; Yang J; Guo Z; Wu T; Sun Y; Zhao L; Ding X; Khan A; Li H
    Pak J Pharm Sci; 2019 May; 32(3):957-962. PubMed ID: 31278706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
    Sasijareonrat N; Jahn N; Ungprasert P; Owattanapanich W
    Technol Cancer Res Treat; 2020; 19():1533033820937008. PubMed ID: 32583728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on different compound combinations of Realgar-Indigo naturalis formula to reverse acute promyelocytic leukemia arsenic resistance by regulating autophagy through mTOR pathway.
    Li R; Xue C; Pan Y; Li G; Huang Z; Xu J; Zhang J; Chen X; Hou L
    J Ethnopharmacol; 2024 May; 326():117778. PubMed ID: 38310990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of scientific compatibility of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia from the perspective of toxicology.
    Jiang Z; Sun Y; Wu Z; Tang M; Ye A; Tu B; Yi J; Xu H; Gao Y
    J Ethnopharmacol; 2023 Dec; 317():116895. PubMed ID: 37467822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor effects and apoptosis induction by Realgar bioleaching solution in Sarcoma-180 cells in vitro and transplanted tumors in mice in vivo.
    Xie QJ; Cao XL; Bai L; Wu ZR; Ma YP; Li HY
    Asian Pac J Cancer Prev; 2014; 15(6):2883-8. PubMed ID: 24761919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Realgar (As
    Li Z; Zhang R; Yin X; Li N; Cui S; Wang T; Tan X; Shen M; Guo Y; Wang J; Guo D; Xu R
    Aging (Albany NY); 2022 Sep; 14(17):7109-7125. PubMed ID: 36098742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study.
    Yang MH; Wan WQ; Luo JS; Zheng MC; Huang K; Yang LH; Mai HR; Li J; Chen HQ; Sun XF; Liu RY; Chen GH; Feng X; Ke ZY; Li B; Tang YL; Huang LB; Luo XQ
    Am J Hematol; 2018 Dec; 93(12):1467-1473. PubMed ID: 30160789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial.
    Zhang X; Liu L; Yao Y; Gong S; Wang M; Xi J; Chen L; Wei S; Zhang H; Zhao C; Wang H
    Trials; 2020 Jan; 21(1):7. PubMed ID: 31898521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia.
    Liao LH; Chen YQ; Huang DP; Wang LN; Ye ZL; Yang LH; Mai HR; Li Y; Liang C; Luo JS; Wang LN; Luo XQ; Tang YL; Zhang XL; Huang LB
    Cancer Chemother Pharmacol; 2022 Jul; 90(1):45-52. PubMed ID: 35760920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia.
    Wang L; Zhou GB; Liu P; Song JH; Liang Y; Yan XJ; Xu F; Wang BS; Mao JH; Shen ZX; Chen SJ; Chen Z
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4826-31. PubMed ID: 18344322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of two-dimensional electrophoresis proteomic profiles of retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells with apoptosis induced by realgar].
    Qi J; Zhang M; He PC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Mar; 31(3):391-6. PubMed ID: 21485086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia.
    Lou Y; Ma Y; Jin J; Zhu H
    Front Oncol; 2020; 10():597601. PubMed ID: 33614484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway.
    Zhao XY; He ZW; Wu D; Xu RZ
    Chin Med J (Engl); 2007 May; 120(9):802-6. PubMed ID: 17531122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of plumbagin on the human acute promyelocytic leukemia cells in vitro].
    Zhao YL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):208-11. PubMed ID: 16638181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
    Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
    Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
    Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
    Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GP7 induces internucleosomal DNA fragmentation independent of caspase activation and DNA fragmentation factor in NB4 cells.
    Qi SN; Jing YX; Dong GX; Chen Y; Yoshida A; Ueda T
    Oncol Rep; 2007 Jul; 18(1):273-7. PubMed ID: 17549379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of apoptosis in human leukemia NB4 cells induced by total astragalosides].
    Hu XY; Xia RX; Cheng CB; Yang MZ; Zeng QS; Xia HL; Li JJ
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):345-8. PubMed ID: 21875462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The simpler, the better: oral arsenic for acute promyelocytic leukemia.
    Zhu HH; Hu J; Lo-Coco F; Jin J
    Blood; 2019 Aug; 134(7):597-605. PubMed ID: 31113776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
    Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
    Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.